Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22119370.
- Also identified by DOI 10.1016/j.radonc.2011.11.003 and PMC identifier 3327779.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prospective analysis was performed of self-reported and biochemically confirmed tobacco use in 50 head and neck cancer patients during treatment. With 93.5% compliance to complete weekly self-report and biochemical confirmatory tests, 29.4% of smokers required biochemical assessment for identification. Accuracy increased by 14.9% with weekly vs. baseline self-reported assessments. Data confirm that head and neck cancer patients misrepresent true tobacco use during treatment.
Medical subject headings
- Head and Neck Neoplasms
- Smoking